Tech Company Financing Transactions
Neuronoff Funding Round
Neuronoff, based in Cleveland, secured $4.5 million in investment from private investors.
Transaction Overview
Company Name
Announced On
10/8/2025
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its Injectrode platform toward FDA clearance and commercial launch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11000 Cedar Ave. 290
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Undisclosed
Website
Email Address
Overview
Neuronoff is at the forefront of neuromodulation technology, specializing in minimally invasive solutions for chronic conditions. The company's flagship product, the Injectrode®, is pioneering elegant neuromodulation therapies to offer Drug-Free and Non-Opioid alternatives for conditions ranging from chronic pain to autonomic, bladder, cardiac, and inflammatory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Manfred Franke
Browse more venture capital transactions:
Prev: 10/8/2025: Affinia Therapeutics venture capital transaction
Next: 10/8/2025: Glue venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs